Nature Chemical Biology, Published online: 02 March 2020; doi:10.1038/s41589-020-0490-4
Tuning CRISPR–Cas9 nuclease specificity enables precision genome engineering. Identifying arginine residues along the bridge helix of SpCas9 that mediate Cas9 mismatch sensitivity enabled engineering of Cas9 with increased specificity in human cells.Robertvk
Shared posts
Bridge helix arginines play a critical role in Cas9 sensitivity to mismatches
[ASAP] High Li+ and Mg2+ Conductivity in a Cu-Azolate Metal–Organic Framework
Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases
Sulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseases
Nature Communications, Published online: 16 November 2016; doi:10.1038/ncomms13386
High levels of homocysteine in cells are linked to pathological states. Here, the authors report that homocysteine inactivates catalase by modifying the heme group, impairing cellular redox homeostasis, and show that this modification occurs in cancer cells and in a cellular model of Parkinson’s disease.
Synthesis of a selective HDAC6 inhibitor active in neuroblasts
Source:Bioorganic & Medicinal Chemistry Letters, Volume 26, Issue 20
Author(s): Vincent Zwick, Claudia A. Simões-Pires, Alessandra Nurisso, Charlotte Petit, Carolina Dos Santos Passos, Giuseppe Marco Randazzo, Nadine Martinet, Philippe Bertrand, Muriel Cuendet
In recent years, the role of HDAC6 in neurodegeneration has been partially elucidated, which led some authors to propose HDAC6 inhibitors as a therapeutic strategy to treat neurodegenerative diseases. In an effort to develop a selective HDAC6 inhibitor which can cross the blood brain barrier (BBB), a modified hydroxamate derivative (compound 3) was designed and synthetized. This compound was predicted to have potential for BBB penetration based on in silico and in vitro evaluation of passive permeability. When tested for its HDAC inhibitory activity, the IC50 value of compound 3 towards HDAC6 was in the nM range in both enzymatic and cell-based assays. Compound 3 showed a cell-based selectivity profile close to that of tubastatin A in SH-SY5Y human neuroblastoma cells, and a good BBB permeability profile.
Graphical abstract
Enhancing the Acyltransferase Activity of Candida antarctica Lipase A by Rational Design
Abstract
A few lipases, such as Candida antarctica lipase A (CAL-A), are known to possess acyltransferase activity. This enables the enzyme to synthesize fatty acid esters from natural oils and alcohols even in the presence of bulk water. Unfortunately, fatty acids are still formed in these reactions as undesired side-products. To reduce the amount of fatty acids, several CAL-A variants were rationally designed based on its crystal structure. These variants were expressed in Escherichia coli and Pichia pastoris, purified, and their acyltransferase/hydrolase activities were investigated by various biocatalytic approaches. Among the investigated variants, mutant Asp122Leu showed a significant decrease in the hydrolytic activity, thus reducing the side-product yield during acylation. As desired, this variant retained wild-type process-relevant features like pH profile and thermostability.
Acyltransferase activity of CAL-A: Analysis of the CAL-A structure suggested 28 single-mutant variants to favor the desired acyltransferase activity. After screening, variant Asp122Leu exhibited significantly reduced production of free fatty acids, whereas the catalytic properties (e.g., thermostability, pH optimum) were not significantly altered.
Stereodivergent Total Synthesis of Δ9-Tetrahydrocannabinols
RobertvkNice work!
Abstract
All four stereoisomers of Δ9-tetrahydrocannabinol (Δ9-THC) were synthesized in concise fashion using stereodivergent dual catalysis. Thus, following identical synthetic sequences and applying identical reaction conditions to the same set of starting materials, selective access to the four stereoisomers of THC was achieved in five steps.
No stereoisomer left behind: A concise synthesis of tetrahydrocannabinol (THC) is described that provides rapid and controlled access to any stereoisomer of the product, including the naturally occurring stereoisomers Δ9-trans-THC and Δ9-cis-THC. By application of stereodivergent dual catalysis to the same set of starting materials, all four isomers of THC were obtained in five steps using a uniform synthetic sequence and identical reaction conditions.